about
Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis preventionDigitoxin and its analogs as novel cancer therapeuticsBreast cancer brain metastases: the last frontierNovel antidotes for target specific oral anticoagulantsGATA family transcriptional factors: emerging suspects in hematologic disordersAllogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioningDistinct genetic alterations in small cell carcinoma from different anatomic sitesCohesin mutations in myeloid malignancies: underlying mechanismsLong noncoding RNAs: pivotal regulators in acute myeloid leukemiaParaneoplastic neurological complications of breast cancer.Current management and prognostic features for gastrointestinal stromal tumor (GIST)Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cellsAdvances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapyMetaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.Publish, not perish: Introducing Experimental Hematology & OncologyEculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation.Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysisPediatric T-cell prolymphocytic leukemia with an isolated 12(p13) deletion and aberrant CD117 expression.Epidemiologic study of myelodysplastic syndromes in a multiethnic, inner city cohortSuccessful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.Do novo del(9)(p13) in a childhood T-cell prolymphocytic leukemia as sole abnormalityGemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity.A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trialAtypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumabAdult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesionsApixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature.Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemiaAcute myeloid leukemia with t(7;21)(p22;q22) and 5q deletion: a case report and literature reviewThe development of bispecific antibodies and their applications in tumor immune escape.Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma.Circulating MicroRNAs in gynecological malignancies: from detection to predictionClinical implications of c-maf expression in plasma cells from patients with multiple myeloma.Childhood B-acute lymphoblastic leukemia: a genetic update.The role of cullin4B in human cancers.Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis.PTEN is a negative regulator of mitotic checkpoint complex during the cell cycleAltered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target eraNeuroblastoma of the elderly, an oncologist's nightmare: case presentation, literature review and SEER database analysis.Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone
P1433
Q21195742-5669E98C-6AE6-4A85-AA59-83CF98A94DC6Q21195743-4934D763-8E14-4691-9576-EEBEF2F88D01Q26775663-32A317D7-8902-45A6-9BF2-4B2C4B7511CFQ26784125-8510F5E2-4C1C-452C-89AE-BC804E3F3E3DQ26786487-1D660C72-2453-404D-8F1E-F4B350A4481FQ26795740-2E006093-8474-40E6-83CD-FE200B8ACA17Q27008242-5BDE6C98-1B0E-467B-950F-C1967B92FA92Q27022740-2717736D-E152-40F4-B1B0-7F4C00A2E61FQ28077492-3DCB11F3-E88F-438B-8737-ED2F564D0CD9Q28077708-07D105BC-F132-4870-B6C2-861E21CC3144Q28391684-3764B385-7238-4ECD-8549-6CE007299369Q28396209-BF833623-4ACB-4180-A1D0-C50E0931A5E2Q28829239-0C8077DD-78A2-415F-B8F5-3C25AC2EC2EBQ30447049-061AC006-9FE5-471F-B642-3E48FD00CAAFQ30485837-D29265C2-A416-455C-A70E-7DBA2793A8E4Q33404676-4E20E4C4-1439-46D1-AB27-9C4AF8898B97Q33404677-B5EE5502-F37F-4E0D-ABEE-258E5D6C7D65Q33404679-C684CF73-95B0-4FC2-82B9-2498D34EF710Q33417395-E136C751-3252-43DE-85D4-2F9283E16E46Q33420286-8F853098-E631-4F12-AF8C-585A9EAE8A7DQ33422687-2940E6B2-7266-498A-98D1-7B40BAD05F1EQ33426575-14119212-4D49-4084-95AE-697061F9F3C1Q33431621-9BD406BB-31FC-4320-9F97-39B1E164C965Q33438559-210EA693-DD59-426C-9795-CC497184BBE0Q33440925-B4679B3A-F9F9-42FE-B8BD-A907F4E6E5AEQ33443809-6A5C1C30-F796-4156-8CCF-E3CAE7099426Q33564364-D33C15D3-E8EF-4C2C-8473-5E4A404589CDQ33574980-7347FC17-4902-426E-A8E1-56F1C9A89501Q33630292-C7A9D049-F019-4E62-B398-0CBB97938CF7Q33654429-88C55B64-A11D-4864-B8C4-0D2B517594CBQ33718986-5C5966F5-AD9E-4C70-BEBD-C975C04B1FBAQ33733709-B7AAEB77-29E1-468C-8DAB-0160926BFFB2Q33777616-8392AE35-4980-4452-B5F2-50DC8CCAC3D8Q33802187-797BB578-3B89-4B97-B736-FCC3A5D0C820Q33810422-7297EA8B-5235-4C7E-B486-0A70DF7BA104Q33857310-5F810AAA-596E-4B9F-94F4-634EEA0C3B52Q33862129-71117943-E5F8-4E31-81B9-A8253B1CC368Q33909086-8A70A60C-F79E-4C2B-9A0D-594954BAF2F9Q33959295-6F5F98E7-4436-4C2D-88A3-4B37C714998FQ34212446-186B3486-5836-465B-9317-A142B31CA6AE
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van BioMed Central
@nl
wissenschaftliche Fachzeitschrift
@de
name
Experimental Hematology & Oncology
@ast
Experimental Hematology & Oncology
@en
Experimental Hematology & Oncology
@es
Experimental Hematology & Oncology
@it
Experimental Hematology & Oncology
@nl
type
label
Experimental Hematology & Oncology
@ast
Experimental Hematology & Oncology
@en
Experimental Hematology & Oncology
@es
Experimental Hematology & Oncology
@it
Experimental Hematology & Oncology
@nl
altLabel
Experimental Hematology and Oncology
@en
prefLabel
Experimental Hematology & Oncology
@ast
Experimental Hematology & Oncology
@en
Experimental Hematology & Oncology
@es
Experimental Hematology & Oncology
@it
Experimental Hematology & Oncology
@nl
P31
P3181
P1055
P1156
21100459104
P123
P1277
P1476
Experimental Hematology & Oncology
@en